Diabetes 56:1240-1247, 2007 DOI: 10.2337/db06-0495 © 2007 by the American Diabetes Association
Systemic Expression of Heme Oxygenase-1 Ameliorates Type 1 Diabetes in NOD MiceFrom the Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of China Address correspondence and reprint requests to Lee-Young Chau, PhD, Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan, Republic of China. E-mail: lyc{at}ibms.sinica.edu.tw
Abbreviations:
AAV, adeno-associated virus; APC, antigen-presenting cell; ConA, concanavalin A; FITC, fluorescein isothiocyanate; HO-1, heme oxygenase-1; IFN-
Heme oxygenase-1 (HO-1) is an enzyme with potent immunoregulatory capacity. To evaluate the effect of HO-1 on autoimmune diabetes, female NOD mice at 9 weeks of age received a single intravenous injection of a recombinant adeno-associated virus bearing HO-1 gene (AAV-HO-1; 0.5 x 1010-2.5 x 1010 viruses/mouse). In a dose-dependent manner, HO-1 transduction reduced destructive insulitis and the incidence of overt diabetes examined over a 15-week period. HO-1–mediated protection was associated with a lower type 1 T-helper cell (Th1)–mediated response. Adaptive transfer experiments in NOD.scid mice demonstrated that splenocytes isolated from AAV-HO-1–treated mice were less diabetogenic. Flow cytometry analysis revealed no significant difference in the percentages of CD4+CD25+ regulatory T-cells between saline-treated and AAV-HO-1–treated groups. However, the CD11c+ major histocompatibility complex II+ dendritic cell population was much lower in the AAV-HO-1–treated group. A similar protective effect against diabetes was observed in NOD mice subjected to carbon monoxide (CO) gas (250 ppm CO for 2 h, twice per week). These data suggest that HO-1 slows the progression to overt diabetes in pre-diabetic NOD mice by downregulating the phenotypic maturity of dendritic cells and Th1 effector function. CO appears to mediate at least partly the beneficial effect of HO-1 in this disease setting.
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||